Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01001559 · ClinicalTrials.gov registry record
Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis
A clinical trial, sponsored by Pamlab.
- Completed
- Registry status
- 242
- Enrollment target
NCT01001559 is a clinical trial that has completed, run by Pamlab. The registered enrollment target is 242 participants.
The verdict
NCT01001559 has completed, sponsored by Pamlab.
- COMPLETED
- Registry status
- 242 participants
- Enrollment target
Study Summary
This is a retrospective chart review study to determine if Deplin® 7.5mg-15mg combined with an antidepressant is better than an antidepressant alone in adults with major depression.
Interventions
- DRUG L-methylfolate
- DRUG Selective serotonin reuptake inhibitor (SSRI)
- DRUG Serotonin and norepinephrine reuptake inhibitor (SNRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2009-08 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01001559
The ClinicalTrials.gov registry entry for NCT01001559 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pamlab, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which L-methylfolate is the first listed.
NCT01001559 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01001559 about?
NCT01001559 is a clinical study titled "Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis". This is a retrospective chart review study to determine if Deplin® 7.5mg-15mg combined with an antidepressant is better than an antidepressant alone in adults with major depression.
What is the current status of trial NCT01001559?
This trial is currently completed. The enrollment target is 242 participants. The study started on 2009-08. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01001559?
The interventions under investigation include: L-methylfolate (DRUG), Selective serotonin reuptake inhibitor (SSRI) (DRUG), Serotonin and norepinephrine reuptake inhibitor (SNRI) (DRUG).
Who is sponsoring clinical trial NCT01001559?
This trial is sponsored by Pamlab, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.